Cleveland Clinic will acquire a stake in Strolll through an exclusive software license agreement, according to a news release Strolll shared with Becker’s. Additionally, as part of this new agreement, Strolll will integrate a digital therapeutic module called Dual-task Augmented Reality Treatment (DART), developed by Cleveland Clinic researchers, into its platform.
DART aims to assist the nearly 80% of Parkinson’s patients who experience falls annually due to difficulties with postural instability and gait dysfunction. According to the release, patients using the DART platform wear augmented reality glasses, and complete a series of tasks that challenge both their body and mind. The platform simultaneously measures their gait and cognitive performance throughout the training.
After the initial integration of the DART platform, Strolll will also establish its U.S. headquarters on Cleveland Clinic’s main campus in Cleveland.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
